These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14724015)

  • 1. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Powles T; Shamash J; Liu W
    Lancet; 2004 Jan; 363(9402):82. PubMed ID: 14724015
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Blumberg N; Heal JM
    Lancet; 2004 Jan; 363(9402):80-1; author reply 81-2. PubMed ID: 14724011
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Freidlin B; Korn EL
    Lancet; 2004 Jan; 363(9402):81; author reply 81-2. PubMed ID: 14724012
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Leyland-Jones B; Mahmud S
    Lancet; 2004 Jan; 363(9402):80; author reply 81-2. PubMed ID: 14724010
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Haddad R; Posner M
    Lancet; 2004 Jan; 363(9402):79-80; author reply 81-2. PubMed ID: 14724009
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Janecka IP
    Lancet; 2004 Mar; 363(9413):993-4. PubMed ID: 15043978
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Kaanders JH; van der Kogel AJ
    Lancet; 2004 Jan; 363(9402):78-9; author reply 81-2. PubMed ID: 14724007
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comment on the article by M. Henke: "Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomized, double blind, placebo controlled trial" or how a cytokine remains a cytokine].
    Lartigau E; Denis F
    Cancer Radiother; 2004 Jun; 8(3):131-3. PubMed ID: 15217580
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Gemici C
    Lancet; 2004 Mar; 363(9413):992-3; author reply 993. PubMed ID: 15043975
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Vaupel P; Mayer A
    Lancet; 2004 Mar; 363(9413):992; author reply 993. PubMed ID: 15043976
    [No Abstract]   [Full Text] [Related]  

  • 11. Controversial effect of epoetin in cancer: grounds for a translational research exercise?
    Apolone G
    Eur J Cancer; 2004 Jun; 40(9):1289-91. PubMed ID: 15177486
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: is it still a reasonable option or too dangerous?
    Rades D
    Oral Oncol; 2009 Feb; 45(2):91-3. PubMed ID: 18490191
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.
    Henke M; Laszig R; Rübe C; Schäfer U; Haase KD; Schilcher B; Mose S; Beer KT; Burger U; Dougherty C; Frommhold H
    Lancet; 2003 Oct; 362(9392):1255-60. PubMed ID: 14575968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythropoietin and anemia: when quality of life and survival clash].
    Fayette J
    Bull Cancer; 2003 Dec; 90(12):1033. PubMed ID: 14715420
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anaemia and radiation therapy].
    Denis F; Lartigau E
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S14-23. PubMed ID: 15679242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concern about the safety of erythropoietin in cancer patients].
    van der Lelie J
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):920-2. PubMed ID: 18561786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin in cancer treatment: considerations about Henke's article.
    Biete Sola A; Calvo Manuel FA; Clavo Varas B; Fernández Pérez C; Porto Vázquez C; de la Torre Tomás A; Zapatero Laborda A
    Clin Transl Oncol; 2005 Sep; 7(8):332-5. PubMed ID: 16185601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin pathophysiology and erythropoietin deficiency anemia.
    Cazzola M
    Hematol J; 2004; 5 Suppl 3():S100-3. PubMed ID: 15190288
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies explore factors that underlie varied responses to cancer drugs.
    Hampton T
    JAMA; 2008 Jul; 300(2):155-6. PubMed ID: 18612107
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?
    Tefferi A
    Mayo Clin Proc; 2007 Nov; 82(11):1316-8. PubMed ID: 17976350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.